Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

Serious adverse events (number of events) · people with early‐ or very early‐stage hepatocellular carcinoma eligible for surgery

Surgery may leads to higher serious adverse events (number of events) compared with radiofrequency ablation (low certainty).

1 finding from 1 review

Management of people with early‐ or very early‐stage hepatocellular carcinoma 2017 · Cochrane Headline outcomes only
Rate ratio 7.02 [2.29, 21.46]
2 studies · 391 participants
Low

Serious adverse events (number of participants) · people with early‐ or very early‐stage hepatocellular carcinoma eligible for surgery

Surgery may leads to higher serious adverse events (number of participants) compared with radiofrequency ablation (low certainty).

1 finding from 1 review

Management of people with early‐ or very early‐stage hepatocellular carcinoma 2017 · Cochrane Headline outcomes only
OR 17.96 [2.28, 141.6]
1 study · 120 participants
Low